|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Investment securities available for sale at fair value (amortized cost June 30, 2026 $1,022,607; December 31, 2025 $957,295) | ||||||||||||||||||||
| Stock of Federal Home Loan Bank | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Loans, net of allowance for credit losses June 30, 2026 $54,921; December 31, 2025 $58,204 | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Tax credit real estate | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Deferred income taxes, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Noninterest-bearing deposits | ||||||||||||||||||||
| Interest-bearing deposits | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Other short-term borrowings, federal funds purchased | ||||||||||||||||||||
| Other short-term borrowings, including FHLB daily reset advances | ||||||||||||||||||||
| Federal Home Loan Bank borrowings | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Allowance for credit losses on off-balance sheet credit exposures | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Redeemable Common Stock Held by Employee Stock Ownership Plan (ESOP) | ||||||||||||||||||||
| STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Common stock, no par value; authorized 40,000,000 shares; issued June 30, 2026 20,677,074 shares; December 31, 2025 20,679,906 shares | ||||||||||||||||||||
| Paid in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Treasury stock at cost (June 30, 2026 3,205,977 shares; December 31, 2025 3,113,780 shares) | ||||||||||||||||||||
| Total Stockholders' Equity | ||||||||||||||||||||
| Less maximum cash obligation related to ESOP shares (Note 10) | ||||||||||||||||||||
| Less maximum cash obligation related to ESOP shares | ||||||||||||||||||||
| Total Stockholders' Equity Less Maximum Cash Obligation Related to ESOP Shares | ||||||||||||||||||||
| Total Liabilities & Stockholders' Equity | ||||||||||||||||||||
Loading...
